Innospec, Inc. (IOSP)
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
$93.95+0.89%
Close 2026-09-04 · 1-day change
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
Intact: The reason to own it still holds.
Innospec grows revenue about 7% a year. Profit margins stay stable near current levels. The company returns capital with $75 million buybacks and $0.92 dividends. Earnings beat recent quarters, showing steady execution.
Revenue growth could slow below 3%. Profit margins might compress from cost pressures. Buybacks and dividends could be cut if cash flow weakens.
The price is about 1% below our fair value near $83. Analysts expect roughly 7.5% revenue growth. Our view aligns with these expectations.
Breaks if: buyback program or dividend cut or suspension
The company has authorized a share repurchase program of up to $75 million.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable compounder with a focus on growth and shareholder returns. The current thesis is supported by strong recent financial performance and consistent management priorities.
The market appears to have priced in a neutral valuation, with expectations suggesting a slight premium compared to peers. There is a low expectations gap, indicating that the market does not anticipate significant changes in performance.
Fundamentals are likely to continue reflecting strong performance, particularly in the Performance Chemicals and Fuel Specialties segments. Management's focus on growth and margin improvement is on track, although there is a moderate risk of missing future guidance.
The thesis hinges on management's ability to maintain guidance and deliver on growth targets. Additionally, external factors like inflation trends and the performance of sector bellwethers will play a crucial role in shaping future outcomes.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The latest earnings beat supports the thesis of strong growth. However, cash flow issues could hinder working capital efficiency, posing a threat to the outlook.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: profit margin declines more than 200 basis points next year
Breaks if: YoY revenue growth falls below 5% next year
Overall, IOSP's strong management and recent performance position it well for the next few years, but external factors could impact its trajectory. Not investment advice.